Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 447
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Edmonton, Montreal, Baltimore MD, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06535607
Phase2, Recruiting
Active & Responsive
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
for
Advanced Solid Tumors
Location: Edmonton, Milwaukee WI, Grand Rapids MI, Hamilton,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05067283
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Edmonton, Calgary, Lethbridge, New Westminster,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Active & Responsive
Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea
for
Sleep Apnea, Obstructive
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT05497180
Phase1, Recruiting
Active & Responsive
Photobiomodulation for Pediatric Hypertrophic Tonsils
for
Pediatric Sleep Apnea, Obstructive Sleep Apnea,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 6 - 12
Code: NCT05459935
Recruiting
Active & Responsive
Exploring the Use of Phototherapy to Improve CPAP Compliance
for
Obstructive Sleep Apnea
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT06960161
Phase1, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity